Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
- Ghent University
- VIB
- KU LEUVEN
- Nature Careers
- University of Antwerp
- Vrije Universiteit Brussel
- Université catholique de Louvain
- IMEC
- Université Libre de Bruxelles (ULB)
- Flanders Institute for Biotechnology
- Hasselt University
- University of Liège
- University of Mons
- Université Catholique de Louvain (UCL)
- Université de Namur
- Université libre de Bruxelles (ULB)
- Vlaamse Instelling voor Technologisch Onderzoek
- Washington State University
- altertox
- 9 more »
- « less
-
Field
-
multiple NCDs across the Brussels Capital Region. It is a collaboration between VUB (including UZB and VUB ETRO), Université Libre de Bruxelles (ULB), and Sciensano. A central innovation is the BEE server
-
. We employ cutting-edge technologies including long-read sequencing, single-nuclei multi-omics, and iPSC-derived models to advance our understanding of disease biology and identify novel biomarkers
-
industrial Ph.D. position focused on developing scalable, Machine Learning (ML) pipelines for genomic and epigenomic biomarker discovery from Oxford Nanopore Technologies (ONT) long-read sequencing data
-
streamlined diagnostic approach for sarcomas that leverages cutting-edge technologies, such as Optical Genome Mapping (OGM, recently validated at UZLeuven) and Multiomic whole-genome Long-Read Sequencing (LRS
-
functional screens and read out mutation identities via barcode sequencing. By providing a direct link between sequence and function MAGESTIC enables massively scaled screens of precise mutations, with
-
functional screens and read out mutation identities via barcode sequencing. By providing a direct link between sequence and function MAGESTIC enables massively scaled screens of precise mutations, with
-
functional screens and read out mutation identities via barcode sequencing. By providing a direct link between sequence and function MAGESTIC enables massively scaled screens of precise mutations, with
-
-regulatory elements typically reduce translation of the primary coding sequence, whereas proteoforms are different protein isoforms translated from the same gene. This project aims to enhance both molecular
-
innovative technologies. The VIB Technologies comprises multiple state-of-the-art core facilities, each with a specific technology focus and embedded within the VIB centers in Ghent, Leuven, or Brussels
-
into risk genes and molecular mechanisms in Frontotemporal Dementia (FTD), while the Sleegers lab specializes in Alzheimer’s Disease (AD), both leveraging next-generation sequencing and innovative